On May 20, 2025 Kura Oncology, Inc. (the "Company") (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, reported that management is scheduled to participate in three upcoming investor conferences (Press release, Kura Oncology, MAY 20, 2025, View Source [SID1234653246]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A fireside chat at the TD Cowen 6th Annual Oncology Innovation Summit held virtually at 9:00 a.m. ET / 6:00 a.m. PT on May 27, 2025;
A fireside chat at the Jefferies Global Healthcare Conference in NYC at 2:35 p.m. ET / 11:35 a.m. PT on June 4, 2025; and
A fireside chat at the Goldman Sachs Annual Global Healthcare Conference in Miami at 11:20 a.m. ET / 8:20 a.m. PT on June 10, 2025.

Live audio webcasts will be available in the Investors section of Kura’s website at View Source, with archived replays available following all three events.